StonvexLoading…
StonvexCore line items from T's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $125.65B | $122.34B | $122.43B | $30.35B |
Operating Income | $24.16B | $19.05B | $23.46B | $5.78B |
Net Income | $21.95B | $10.95B | $14.40B | Not available |
EPS (Diluted) | $3.04 | $1.49 | $1.97 | $0.48 |
Total Assets | $420.20B | $394.80B | $407.06B | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $18.23B | $3.30B | $6.72B | Not available |
Free Cash Flow OCF − CapEx | $19.44B | $18.51B | $20.46B | Not available |
Shares Outstanding | 7.18B | 7.20B | 7.26B | Not available |